查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1679170

商业水产养殖疫苗市场：全球产业分析、规模、份额、成长、趋势及预测（2025-2032）

Commercial Aquaculture Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 366 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球商业水产养殖疫苗市场的综合报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会、驱动因素和挑战，并对市场结构提供了详细的见解。本研究报告采用独家资料和统计数据，概述了 2025 年至 2032 年全球商业水产养殖疫苗市场的预期成长轨迹。

关键见解

  • 商业水产养殖疫苗市场规模（2025年）：4.564亿美元
  • 预计市场价值（2032年）：7.428亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：7.2%

商业水产养殖疫苗市场-报告内容：

商业水产养殖疫苗在养殖水生物种的疾病预防中发挥着至关重要的作用，可确保更高的存活率和更高的生产力。这些疫苗有助于降低细菌、病毒和寄生虫感染的风险，减少对抗生素的依赖，并提高水产养殖实践的永续性。该市场为鱼类养殖场、孵化场和水产养殖公司提供各种疫苗，包括灭活疫苗、减毒活病毒疫苗、重组疫苗和基于 DNA 的疫苗。市场成长的动力来自水产养殖产量的增加、疾病发生率的上升以及促进永续水产养殖实践的严格法规。

市场成长动力：

全球商业水产养殖疫苗市场受到几个关键因素的推动，包括对水产品的需求增加导致水产养殖活动增加。人们对鱼类养殖场疾病爆发及其相关经济损失的日益担忧加强了疫苗的采用。全球监管机构正在实施更严格的指导方针，以减少水产养殖的抗生素使用，进一步推动对疫苗的需求。 DNA疫苗和重组疫苗等技术进步正在提高疫苗的功效和应用，有助于扩大市场。此外，对水产养殖卫生和生物安全措施的投资增加为疫苗的采用创造了新的机会。

市场限制：

儘管成长前景看好，商业水产养殖疫苗市场仍面临高昂的开发成本和漫长的监管核准流程等挑战。不同水环境中疾病管理的复杂性以及鱼类免疫反应的多变性也对疫苗的有效性构成了挑战。特别是在新兴市场，小规模水产养殖场的认知和疫苗采用有限，阻碍了市场渗透。此外，与储存和分发疫苗相关的后勤挑战（包括低温运输要求）增加了营运成本并限制了疫苗的广泛使用。解决这些障碍需要产业相关人员、政府和研究机构之间的合作，以提高疫苗的可用性和可负担性。

市场机会：

随着对更易于管理的新型疫苗製剂（如口服疫苗和浸入式疫苗）的研究不断增加，商业水产养殖疫苗市场提供了巨大的成长机会。精准农业技术的扩展，例如即时疾病监测和自动疫苗接种系统，预计将提高疫苗的有效性和采用率。亚太和拉丁美洲的新兴市场水产养殖业蓬勃发展，为疫苗製造商提供了丰厚的前景。製药公司、水产养殖公司和政府机构之间的策略联盟可以加速疫苗的开发和分发。此外，人们对永续水产养殖实践和环境友善疾病预防解决方案的日益关注为疫苗创新创造了有利的市场环境。

本报告探讨的关键问题

  • 推动全球商业水产养殖疫苗市场成长的关键因素有哪些？
  • 哪些疫苗类型和使用方法正在获得业界支持？
  • 科技进步如何影响疫苗的开发与管理？
  • 市场的主要企业在哪里？他们采用什么策略来获得竞争优势？
  • 全球商业水产养殖疫苗市场有哪些新兴趋势与前景？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值洞察

  • 产品采用分析
  • 水产养殖生产概况
  • 主要国家鱼贝类消费状况
  • 水产养殖疾病爆发－概述
  • 不同给药途径的比较分析
  • 监管状况
  • 价值链分析
  • 波特五力分析
  • PESTLE分析

4. 全球商业水产养殖疫苗市场展望

  • 主要亮点
    • 市场规模及与前一年同期比较率
    • 绝对的商机
  • 市场规模分析与预测
    • 2019-2024 年历史市场规模分析
    • 目前市场规模分析与预测，2025-2032
  • 全球商业水产养殖疫苗市场展望：疫苗类型
    • 简介/主要发现
    • 2019 年至 2024 年疫苗类型市场规模历史分析
    • 2025-2032 年疫苗市场规模分析及预测
      • 惰性
      • 衰减
      • 次单元
      • DNA
    • 市场吸引力分析：疫苗类型
  • 全球商业水产养殖疫苗市场展望：病原体
    • 简介/主要发现
    • 2019 年至 2024 年病原体市场规模历史分析
    • 2025 年至 2032 年病原体市场规模分析与预测
      • 细菌
      • 病毒
    • 市场吸引力分析：病原体
  • 全球商业水产养殖疫苗市场展望：按类型
    • 简介/主要发现
    • 2019 年至 2024 年按类型分類的历史市场规模分析
    • 2025 年至 2032 年按类型分類的当前市场规模分析与预测
      • 鲑鱼
      • 吴郭鱼
      • 鳟鱼
      • 海鲈鱼
      • 鲤鱼
      • 大菱鲆
      • 鲂
      • 其他的
    • 市场吸引力分析：类型
  • 全球商业水产养殖疫苗市场展望：给药途径
    • 简介/主要发现
    • 2019 年至 2024 年按给药途径分類的历史市场规模分析
    • 2025 年至 2032 年按给药途径分類的当前市场规模分析与预测
      • 腹腔内
      • 肌肉注射
      • 浸没
      • 口服
    • 市场吸引力分析：给药途径
  • 全球商业水产养殖疫苗市场展望：最终用户
    • 简介/主要发现
    • 2019 年至 2024 年最终用户市场规模历史分析
    • 2025 年至 2032 年按最终用户分類的当前市场规模分析和预测
      • 水产养殖公司
      • 鱼类兽医诊所
      • 水生生物研究所
    • 市场吸引力分析：最终用户

5. 全球商业水产养殖疫苗市场（按地区）展望

  • 主要亮点
  • 2019 年至 2024 年各地区历史市场规模分析
  • 2025 年至 2032 年各地区目前市场规模分析与预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

6. 北美商业水产养殖疫苗市场展望

7. 欧洲商业水产养殖疫苗市场展望

8. 东亚商业水产养殖疫苗市场展望

9. 南亚和大洋洲商业水产养殖疫苗市场展望

10. 拉丁美洲商业水产养殖疫苗市场展望

11.中东和非洲商业水产养殖疫苗市场展望

第十二章竞争格局

  • 2025年市场占有率分析
  • 市场结构
    • 市场竞争加剧图
    • 竞争仪錶板
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Zoetis Animal Healthcare
    • Merck &Co. Inc.
    • ICTYO, Virbac
    • Phibro Animal Health Corporation
    • Elanco Animal Health Incorporated
    • HIPRA
    • Nisseiken Co., Ltd.
    • Tecnovax SA
    • AQUAVET SA
    • IDT Biologika

第十三章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP32289

Persistence Market Research has recently released a comprehensive report on the worldwide market for commercial aquaculture vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global commercial aquaculture vaccines market from 2025 to 2032.

Key Insights:

  • Commercial Aquaculture Vaccines Market Size (2025E): US$ 456.4 Mn
  • Projected Market Value (2032F):US$ 742.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.2%

Commercial Aquaculture Vaccines Market - Report Scope:

Commercial aquaculture vaccines play a vital role in disease prevention among farmed aquatic species, ensuring higher survival rates and improved productivity. These vaccines help mitigate the risk of bacterial, viral, and parasitic infections, reducing dependence on antibiotics and enhancing sustainability in aquaculture practices. The market caters to fish farms, hatcheries, and aquaculture companies, offering a range of vaccines, including inactivated, live attenuated, recombinant, and DNA-based vaccines. Market growth is driven by increasing aquaculture production, rising disease outbreaks, and stringent regulations promoting sustainable fish farming practices.

Market Growth Drivers:

The global commercial aquaculture vaccines market is propelled by several key factors, including the rising demand for seafood, which has led to an increase in aquaculture activities. Growing concerns about disease outbreaks in fish farms and the subsequent economic losses have intensified the adoption of vaccines. Regulatory bodies worldwide are enforcing stricter guidelines to reduce antibiotic use in aquaculture, further driving vaccine demand. Technological advancements, such as DNA-based and recombinant vaccines, are improving vaccine efficacy and application methods, fostering market expansion. Additionally, increasing investments in aquaculture health management and biosecurity measures are creating new opportunities for vaccine adoption.

Market Restraints:

Despite promising growth prospects, the commercial aquaculture vaccines market faces challenges related to high development costs and the lengthy regulatory approval process. The complexity of disease management in diverse aquatic environments and variations in fish species' immune responses also pose challenges to vaccine effectiveness. Limited awareness and vaccine adoption in small-scale fish farms, particularly in developing regions, hinder market penetration. Furthermore, the logistical challenges associated with vaccine storage and distribution, including cold chain requirements, increase operational costs and restrict widespread availability. Addressing these barriers requires collaborative efforts between industry players, governments, and research institutions to enhance vaccine accessibility and affordability.

Market Opportunities:

The commercial aquaculture vaccines market presents significant growth opportunities driven by increasing research in novel vaccine formulations, including oral and immersion vaccines, which offer ease of administration. The expansion of precision aquaculture technologies, such as real-time disease monitoring and automated vaccination systems, is expected to improve vaccine effectiveness and adoption rates. Emerging markets in Asia-Pacific and Latin America, where aquaculture is rapidly growing, offer lucrative prospects for vaccine manufacturers. Strategic collaborations between pharmaceutical companies, aquaculture firms, and government agencies can accelerate vaccine development and distribution. Additionally, the growing focus on sustainable aquaculture practices and environmentally friendly disease prevention solutions creates a favorable market landscape for vaccine innovation.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the commercial aquaculture vaccines market globally?
  • Which vaccine types and application methods are gaining traction in the industry?
  • How are technological advancements influencing vaccine development and administration?
  • Who are the key players in the market, and what strategies are they employing for competitive advantage?
  • What are the emerging trends and future prospects in the global commercial aquaculture vaccines market?

Competitive Intelligence and Business Strategy:

Leading players in the global commercial aquaculture vaccines market, including Zoetis Inc., Merck Animal Health, and Elanco Animal Health, focus on R&D investments, strategic partnerships, and product innovations to strengthen their market presence. Companies are developing advanced vaccine solutions, such as recombinant and DNA-based vaccines, to enhance efficacy and reduce side effects. Collaborations with aquaculture farms, research institutions, and government agencies are facilitating knowledge exchange and technology adoption. Moreover, expanding manufacturing capabilities, optimizing supply chain logistics, and investing in educational initiatives for fish farmers contribute to market growth and sustainability.

Key Companies Profiled:

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • HIPRA
  • Virbac
  • Phibro Animal Health Corporation
  • Tecnovax
  • Vaxxinova
  • Benchmark Holdings PLC
  • KBNP Inc.

Commercial Aquaculture Vaccines Market Scope

By Vaccine:

  • Inactivated
  • Attenuated
  • Subunit
  • DNA

By Pathogen:

  • Bacteria
  • Virus

By Species:

  • Salmon
  • Tilapia
  • Trout
  • Sea Bass
  • Carp
  • Turbot
  • Bream

By Route of Administration:

  • Intraperitoneal
  • Intramuscular
  • Immersion
  • Oral

By End User:

  • Fish Farming Companies
  • Fish Veterinary Clinics
  • Aquatic Research Institutes

Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Commercial Aquaculture Vaccines Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Aquaculture Fisheries Production Overview
  • 3.3. Fish and Seafood Consumption Scenario, by Key Country
  • 3.4. Aquaculture Disease Outbreaks - Overview
  • 3.5. Comparative Analysis for Various Route of Administration
  • 3.6. Regulatory Landscape
  • 3.7. Value Chain Analysis
  • 3.8. Porter's Five Force Analysis
  • 3.9. PESTLE Analysis

4. Global Commercial Aquaculture Vaccines Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Commercial Aquaculture Vaccines Market Outlook: Vaccine Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Vaccine Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
      • 4.3.3.1. Inactivated
      • 4.3.3.2. Attenuated
      • 4.3.3.3. Subunit
      • 4.3.3.4. DNA
    • 4.3.4. Market Attractiveness Analysis: Vaccine Type
  • 4.4. Global Commercial Aquaculture Vaccines Market Outlook: Pathogen
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Pathogen, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
      • 4.4.3.1. Bacteria
      • 4.4.3.2. Virus
    • 4.4.4. Market Attractiveness Analysis: Pathogen
  • 4.5. Global Commercial Aquaculture Vaccines Market Outlook: Species
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Species, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
      • 4.5.3.1. Salmon
      • 4.5.3.2. Tilapia
      • 4.5.3.3. Trout
      • 4.5.3.4. Sea Bass
      • 4.5.3.5. Carp
      • 4.5.3.6. Turbot
      • 4.5.3.7. Bream
      • 4.5.3.8. Others
    • 4.5.4. Market Attractiveness Analysis: Species
  • 4.6. Global Commercial Aquaculture Vaccines Market Outlook: Route of Administration
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019-2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      • 4.6.3.1. Intraperitoneal
      • 4.6.3.2. Intramuscular
      • 4.6.3.3. Immersion
      • 4.6.3.4. Oral
    • 4.6.4. Market Attractiveness Analysis: Route of Administration
  • 4.7. Global Commercial Aquaculture Vaccines Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.7.3.1. Fish Farming Companies
      • 4.7.3.2. Fish Veterinary Clinics
      • 4.7.3.3. Aquatic Research Institutes
    • 4.7.4. Market Attractiveness Analysis: End User

5. Global Commercial Aquaculture Vaccines Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Commercial Aquaculture Vaccines Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Vaccine Type
    • 6.2.3. By Pathogen
    • 6.2.4. By Species
    • 6.2.5. By Route of Administration
    • 6.2.6. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 6.4.1. Inactivated
    • 6.4.2. Attenuated
    • 6.4.3. Subunit
    • 6.4.4. DNA
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 6.5.1. Bacteria
    • 6.5.2. Virus
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 6.6.1. Salmon
    • 6.6.2. Tilapia
    • 6.6.3. Trout
    • 6.6.4. Sea Bass
    • 6.6.5. Carp
    • 6.6.6. Turbot
    • 6.6.7. Bream
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 6.7.1. Intraperitoneal
    • 6.7.2. Intramuscular
    • 6.7.3. Immersion
    • 6.7.4. Oral
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.8.1. Fish Farming Companies
    • 6.8.2. Fish Veterinary Clinics
    • 6.8.3. Aquatic Research Institutes
  • 6.9. Market Attractiveness Analysis

7. Europe Commercial Aquaculture Vaccines Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Vaccine Type
    • 7.2.3. By Pathogen
    • 7.2.4. By Species
    • 7.2.5. By Route of Administration
    • 7.2.6. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Norway
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. U.K.
    • 7.3.5. Italy
    • 7.3.6. Spain
    • 7.3.7. Russia
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 7.4.1. Inactivated
    • 7.4.2. Attenuated
    • 7.4.3. Subunit
    • 7.4.4. DNA
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 7.5.1. Bacteria
    • 7.5.2. Virus
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 7.6.1. Salmon
    • 7.6.2. Tilapia
    • 7.6.3. Trout
    • 7.6.4. Sea Bass
    • 7.6.5. Carp
    • 7.6.6. Turbot
    • 7.6.7. Bream
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 7.7.1. Intraperitoneal
    • 7.7.2. Intramuscular
    • 7.7.3. Immersion
    • 7.7.4. Oral
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.8.1. Fish Farming Companies
    • 7.8.2. Fish Veterinary Clinics
    • 7.8.3. Aquatic Research Institutes
  • 7.9. Market Attractiveness Analysis

8. East Asia Commercial Aquaculture Vaccines Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Vaccine Type
    • 8.2.3. By Pathogen
    • 8.2.4. By Species
    • 8.2.5. By Route of Administration
    • 8.2.6. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 8.4.1. Inactivated
    • 8.4.2. Attenuated
    • 8.4.3. Subunit
    • 8.4.4. DNA
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 8.5.1. Bacteria
    • 8.5.2. Virus
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 8.6.1. Salmon
    • 8.6.2. Tilapia
    • 8.6.3. Trout
    • 8.6.4. Sea Bass
    • 8.6.5. Carp
    • 8.6.6. Turbot
    • 8.6.7. Bream
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 8.7.1. Intraperitoneal
    • 8.7.2. Intramuscular
    • 8.7.3. Immersion
    • 8.7.4. Oral
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.8.1. Fish Farming Companies
    • 8.8.2. Fish Veterinary Clinics
    • 8.8.3. Aquatic Research Institutes
  • 8.9. Market Attractiveness Analysis

9. South Asia & Oceania Commercial Aquaculture Vaccines Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Vaccine Type
    • 9.2.3. By Pathogen
    • 9.2.4. By Species
    • 9.2.5. By Route of Administration
    • 9.2.6. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 9.4.1. Inactivated
    • 9.4.2. Attenuated
    • 9.4.3. Subunit
    • 9.4.4. DNA
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 9.5.1. Bacteria
    • 9.5.2. Virus
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 9.6.1. Salmon
    • 9.6.2. Tilapia
    • 9.6.3. Trout
    • 9.6.4. Sea Bass
    • 9.6.5. Carp
    • 9.6.6. Turbot
    • 9.6.7. Bream
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 9.7.1. Intraperitoneal
    • 9.7.2. Intramuscular
    • 9.7.3. Immersion
    • 9.7.4. Oral
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.8.1. Fish Farming Companies
    • 9.8.2. Fish Veterinary Clinics
    • 9.8.3. Aquatic Research Institutes
  • 9.9. Market Attractiveness Analysis

10. Latin America Commercial Aquaculture Vaccines Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Vaccine Type
    • 10.2.3. By Pathogen
    • 10.2.4. By Species
    • 10.2.5. By Route of Administration
    • 10.2.6. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 10.4.1. Inactivated
    • 10.4.2. Attenuated
    • 10.4.3. Subunit
    • 10.4.4. DNA
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 10.5.1. Bacteria
    • 10.5.2. Virus
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 10.6.1. Salmon
    • 10.6.2. Tilapia
    • 10.6.3. Trout
    • 10.6.4. Sea Bass
    • 10.6.5. Carp
    • 10.6.6. Turbot
    • 10.6.7. Bream
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 10.7.1. Intraperitoneal
    • 10.7.2. Intramuscular
    • 10.7.3. Immersion
    • 10.7.4. Oral
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.8.1. Fish Farming Companies
    • 10.8.2. Fish Veterinary Clinics
    • 10.8.3. Aquatic Research Institutes
  • 10.9. Market Attractiveness Analysis

11. Middle East & Africa Commercial Aquaculture Vaccines Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Vaccine Type
    • 11.2.3. By Pathogen
    • 11.2.4. By Species
    • 11.2.5. By Route of Administration
    • 11.2.6. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Northern Africa
    • 11.3.4. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Vaccine Type, 2025-2032
    • 11.4.1. Inactivated
    • 11.4.2. Attenuated
    • 11.4.3. Subunit
    • 11.4.4. DNA
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025-2032
    • 11.5.1. Bacteria
    • 11.5.2. Virus
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Species, 2025-2032
    • 11.6.1. Salmon
    • 11.6.2. Tilapia
    • 11.6.3. Trout
    • 11.6.4. Sea Bass
    • 11.6.5. Carp
    • 11.6.6. Turbot
    • 11.6.7. Bream
    • 11.6.8. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 11.7.1. Intraperitoneal
    • 11.7.2. Intramuscular
    • 11.7.3. Immersion
    • 11.7.4. Oral
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.8.1. Fish Farming Companies
    • 11.8.2. Fish Veterinary Clinics
    • 11.8.3. Aquatic Research Institutes
  • 11.9. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Zoetis Animal Healthcare
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Merck & Co. Inc.
    • 12.3.3. ICTYO, Virbac
    • 12.3.4. Phibro Animal Health Corporation
    • 12.3.5. Elanco Animal Health Incorporated
    • 12.3.6. HIPRA
    • 12.3.7. Nisseiken Co., Ltd.
    • 12.3.8. Tecnovax S.A.
    • 12.3.9. AQUAVET S.A.
    • 12.3.10. IDT Biologika

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations